NVIC

Congress Gave More Power To Public Health Officials After 9-11

Published August 30, 2022

After September 11, 2001, Congress enacted the Homeland Security Act of 2002 that reorganized and gave expanded powers to the Executive Branch of the federal government, including creating the Department of Homeland Security. The Federal Emergency Mangagement Agency (FEMA)  was moved to the new Department of Homeland Security. The Department of Homeland Security, which has more than 200,000 employees and it the third largest department of the federal government, works closely with the Department of Health and Human Services (DHHS) to respond to declared public health emergencies.

The U.S. Congress passed the Project Bioshield Act of 2004 and the Pandemic and All Hazards Preparedness Act of 2006 to create and fund a partnership between private pharmaceutical companies and the Department of Health and Human Services to develop bioterrorism and pandemic influenza vaccines that could be used by Americans whenever the U.S. Secretary of Health declares a public health emergency. The National Biodefense Science Board and the Biomedical Advanced Research and Development Authority (BARDA) also were created under the DHHS Office for Preparedness and Response.

An Emergency Use Authorization (EUA) included in Bioshield legislation passed by Congress allows experimental vaccines and other pharmaceutical products to be fast tracked and given to citizens. Congress gave full liability protection to drug companies making experimental vaccines and drugs and to persons enforcing the use of or administering experimental vaccines and drugs that may injure or kill civilians during a declared public health emergency.

The National Vaccine Information Center opposed certain provisions in the Homeland Security Act of 2002  and Bioshield legislation that was passed by Congress and called for responsible congressional oversight on expanded authority granted to federal public health officials by Congress since 9-11.
 

Select disease / vaccine